Nebulised hypertonic saline solution for acute bronchiolitis in infants (Q24200958)

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulised hypertonic saline for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Epinephrine for bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulized hypertonic saline solution for acute bronchiolitis in infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Prevalence and clinical characteristics of human metapneumovirus infections in hospitalized infants in Spain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Stimulation of prostaglandin output from rat stomach by hypertonic solutions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Association of respiratory picornaviruses with acute bronchiolitis in French infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Aerosol delivery in respiratory syncytial virus bronchiolitis: hood or face mask?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulized 5% or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in moderate bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Recent advances in the treatment of bronchiolitis and laryngitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Treatment of acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Management of acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Observer Agreement for Respiratory Signs and Oximetry in Infants Hospitalized with Lower Respiratory Infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

State of the art: bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Effectiveness of nebulized hypertonic saline and epinephrine in hospitalized infants with bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006458.PUB3

7 January 2021

10.1002/14651858.CD006458.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2539187

2539187

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference